Clinical trials
Androgenetic Alopecia (AGA) clinical trials
Below are recruiting androgenetic alopecia (aga) clinical trials, each written for real people, not researchers. We’re tracking 11 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07693244RecruitingPhase 2
Exosome therapy for male pattern baldness
This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.
BeijingAges 18–55 - NCT07603544Recruiting
Hair Loss Study: Understanding Male Pattern Baldness
This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.
Xinxiang, HenanAges 20–65 - NCT07536100Recruiting
New Hair Growth Serum vs. Minoxidil for Hair Loss
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
Bangkok, BangkokAges 18 years+ - NCT07370519RecruitingPhase 2
Probiotic lotion for hair loss
This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.
Shenzhen, GuangdongAges 18–60 - NCT07327359RecruitingPhase 1/Phase 2
Hair loss treatment for men with male pattern baldness
This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.
Botany, New South WalesAges 18–59 - NCT07317544RecruitingPhase 1/Phase 2
ABS-201 trial for hair loss in healthy adults
This trial tests a new medicine (ABS-201) in healthy people to see if it is safe and works for hair loss. It involves multiple doses and compares results based on whether you have the common type of hair loss called androgenetic alopecia.
Sydney, New South WalesAges 18–65 - NCT07080931RecruitingPhase 3
Minoxidil foam for female hair loss
This trial tests a 5% minoxidil foam to treat female pattern hair loss. It may help women who have been diagnosed with this condition and have mild to moderate hair thinning.
BeijingAges 18 years+ - NCT07079657Recruiting
Thulium laser and growth factors for hair loss
This trial tests whether a special laser combined with growth factor injections can help regrow hair in people with common hereditary hair loss (androgenetic alopecia). It aims to find a new treatment option that may work better than current methods.
Hamburg, Free and Hanseatic City of HamburgAges 18 years+ - NCT07012486RecruitingEarly Phase 1
Dihydroartemisinin for female hair loss
This trial tests if dihydroartemisinin, a medicine derived from a plant, can help treat female pattern hair loss. It may be an option for women who haven't used other hair loss treatments recently.
Shanghai, Shanghai MunicipalityAges 18–40 - NCT06764329Enrolling by invitationPhase 1/Phase 2
Stem cell therapy for male hair loss
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
RawalpindiAges 20–59 - NCT07819435RecruitingPhase 2/Phase 3
Topical treatment for male pattern hair loss
This study tests an investigational topical medication called PP405 for male pattern hair loss. It aims to see if the treatment is safe and effective for regrowing hair in men with moderate balding.
Birmingham, AlabamaAges 18–55
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for androgenetic alopecia (aga)?
- Yes. Clin2 currently lists 11 recruiting androgenetic alopecia (aga) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a androgenetic alopecia (aga) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a androgenetic alopecia (aga) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.